N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide

C99H85Cl2F6N27O7 — CID 157308177

IUPACN-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
SMILESCC(=O)OCc1cccc2c1CC(c1[nH]ncc1NC(=O)c1c(F)cccc1F)C2.CN1CCN(Cc2cccc3[nH]c(-c4[nH]ncc4NC(=O)c4c(F)cccc4F)nc23)CC1.O=C(Nc1cn[nH]c1-c1nc2c(CN3CCOCC3)cccc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1c(Cl)cccc1Cl.c1ccc(Nc2cn[nH]c2-c2nc3ccccc3[nH]2)nc1
InChIInChI=1S/C23H23F2N7O.C22H20F2N6O2.C22H19F2N3O3.C17H11Cl2N5O.C15H12N6/c1-31-8-10-32(11-9-31)13-14-4-2-7-17-20(14)29-22(27-17)21-18(12-26-30-21)28-23(33)19-15(24)5-3-6-16(19)25;23-14-4-2-5-15(24)18(14)22(31)27-17-11-25-29-20(17)21-26-16-6-1-3-13(19(16)28-21)12-30-7-9-32-10-8-30;1-12(28)30-11-14-5-2-4-13-8-15(9-16(13)14)21-19(10-25-27-21)26-22(29)20-17(23)6-3-7-18(20)24;18-9-4-3-5-10(19)14(9)17(25)23-13-8-20-24-15(13)16-21-11-6-1-2-7-12(11)22-16;1-2-6-11-10(5-1)19-15(20-11)14-12(9-17-21-14)18-13-7-3-4-8-16-13/h2-7,12H,8-11,13H2,1H3,(H,26,30)(H,27,29)(H,28,33);1-6,11H,7-10,12H2,(H,25,29)(H,26,28)(H,27,31);2-7,10,15H,8-9,11H2,1H3,(H,25,27)(H,26,29);1-8H,(H,20,24)(H,21,22)(H,23,25);1-9H,(H,16,18)(H,17,21)(H,19,20)
InChIKeyBCSVAXZNYNLLLP-UHFFFAOYSA-N
MW1949.84 g/mol
LogP18.04
Rot. Bonds21

About N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide

N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide (PubChem CID 157308177) has the molecular formula C99H85Cl2F6N27O7 and a molecular weight of 1949.84 g/mol. Its IUPAC name is N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide.

Molecular Properties

Compound NameN-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
PubChem CID157308177
Molecular FormulaC99H85Cl2F6N27O7
Molecular Weight1949.84 g/mol
Exact Mass1947.64
IUPAC NameN-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide
SMILESCC(=O)OCc1cccc2c1CC(c1[nH]ncc1NC(=O)c1c(F)cccc1F)C2.CN1CCN(Cc2cccc3[nH]c(-c4[nH]ncc4NC(=O)c4c(F)cccc4F)nc23)CC1.O=C(Nc1cn[nH]c1-c1nc2c(CN3CCOCC3)cccc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1c(Cl)cccc1Cl.c1ccc(Nc2cn[nH]c2-c2nc3ccccc3[nH]2)nc1
InChIInChI=1S/C23H23F2N7O.C22H20F2N6O2.C22H19F2N3O3.C17H11Cl2N5O.C15H12N6/c1-31-8-10-32(11-9-31)13-14-4-2-7-17-20(14)29-22(27-17)21-18(12-26-30-21)28-23(33)19-15(24)5-3-6-16(19)25;23-14-4-2-5-15(24)18(14)22(31)27-17-11-25-29-20(17)21-26-16-6-1-3-13(19(16)28-21)12-30-7-9-32-10-8-30;1-12(28)30-11-14-5-2-4-13-8-15(9-16(13)14)21-19(10-25-27-21)26-22(29)20-17(23)6-3-7-18(20)24;18-9-4-3-5-10(19)14(9)17(25)23-13-8-20-24-15(13)16-21-11-6-1-2-7-12(11)22-16;1-2-6-11-10(5-1)19-15(20-11)14-12(9-17-21-14)18-13-7-3-4-8-16-13/h2-7,12H,8-11,13H2,1H3,(H,26,30)(H,27,29)(H,28,33);1-6,11H,7-10,12H2,(H,25,29)(H,26,28)(H,27,31);2-7,10,15H,8-9,11H2,1H3,(H,25,27)(H,26,29);1-8H,(H,20,24)(H,21,22)(H,23,25);1-9H,(H,16,18)(H,17,21)(H,19,20)
InChIKeyBCSVAXZNYNLLLP-UHFFFAOYSA-N
XLogP18.04
TPSA444.69 Ų
H-Bond Donors14
H-Bond Acceptors21
Rotatable Bonds21
Heavy Atoms141
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001949.84
LogP ≤ 518.04
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1021

Analyze N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide?
The IUPAC name of N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide (CID 157308177) is N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide.
What is the SMILES notation for N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide?
The canonical SMILES for N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide is CC(=O)OCc1cccc2c1CC(c1[nH]ncc1NC(=O)c1c(F)cccc1F)C2.CN1CCN(Cc2cccc3[nH]c(-c4[nH]ncc4NC(=O)c4c(F)cccc4F)nc23)CC1.O=C(Nc1cn[nH]c1-c1nc2c(CN3CCOCC3)cccc2[nH]1)c1c(F)cccc1F.O=C(Nc1cn[nH]c1-c1nc2ccccc2[nH]1)c1c(Cl)cccc1Cl.c1ccc(Nc2cn[nH]c2-c2nc3ccccc3[nH]2)nc1.
What is the InChIKey of N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide?
The InChIKey is BCSVAXZNYNLLLP-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H23F2N7O.C22H20F2N6O2.C22H19F2N3O3.C17H11Cl2N5O.C15H12N6/c1-31-8-10-32(11-9-31)13-14-4-2-7-17-20(14)29-22(27-17)21-18(12-26-30-21)28-23(33)19-15(24)5-3-6-16(19)25;23-14-4-2-5-15(24)18(14)22(31)27-17-11-25-29-20(17)21-26-16-6-1-3-13(19(16)28-21)12-30-7-9-32-10-8-30;1-12(28)30-11-14-5-2-4-13-8-15(9-16(13)14)21-19(10-25-27-21)26-22(29)20-17(23)6-3-7-18(20)24;18-9-4-3-5-10(19)14(9)17(25)23-13-8-20-24-15(13)16-21-11-6-1-2-7-12(11)22-16;1-2-6-11-10(5-1)19-15(20-11)14-12(9-17-21-14)18-13-7-3-4-8-16-13/h2-7,12H,8-11,13H2,1H3,(H,26,30)(H,27,29)(H,28,33);1-6,11H,7-10,12H2,(H,25,29)(H,26,28)(H,27,31);2-7,10,15H,8-9,11H2,1H3,(H,25,27)(H,26,29);1-8H,(H,20,24)(H,21,22)(H,23,25);1-9H,(H,16,18)(H,17,21)(H,19,20).
What are the key properties of N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide?
N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide has a molecular weight of 1949.84 g/mol, XLogP of 18.04, 21 rotatable bonds, 14 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]-2,6-dichlorobenzamide;N-[5-(1H-benzimidazol-2-yl)-1H-pyrazol-4-yl]pyridin-2-amine;[2-[4-[(2,6-difluorobenzoyl)amino]-1H-pyrazol-5-yl]-2,3-dihydro-1H-inden-4-yl]methyl acetate;2,6-difluoro-N-[5-[4-[(4-methylpiperazin-1-yl)methyl]-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2,6-difluoro-N-[5-[4-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide is sourced from PubChem (CID 157308177), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).